Overexpression of RBBP6, alone or combined with mutant TP53, is predictive of poor prognosis in colon cancer.

by Jian Chen, Huamei Tang, Zehua Wu, Chongzhi Zhou, Tao Jiang, Yingming Xue, Guoyu Huang, Dongwang Yan, Zhihai Peng
Published 2013-01-01

Liquid Biopsy in Lung Cancer Screening: The Contribution of Metabolomics. Results of A Pilot Study

by Sandeep Singhal, Christian Rolfo, Andrew W. Maksymiuk, Paramjit S. Tappia, Daniel S. Sitar, Alessandro Russo, Parveen S. Akhtar, Nazrina Khatun, Parveen Rahnuma, Ahmed Rashiduzzaman, Rashid Ahmed Bux, Guoyu Huang, Bram Ramjiawan
Published 2019-07-01

A High-Performing Plasma Metabolite Panel for Early-Stage Lung Cancer Detection

by Lun Zhang, Jiamin Zheng, Rashid Ahmed, Guoyu Huang, Jennifer Reid, Rupasri Mandal, Andrew Maksymuik, Daniel S. Sitar, Paramjit S. Tappia, Bram Ramjiawan, Philippe Joubert, Alessandro Russo, Christian D. Rolfo, David S. Wishart
Published 2020-03-01